Lactobacillus -mediated weight loss may be brought about, at least in part, by changes to lipid absorption and triglyceride synthesis, since orally-administered Lactobacillus rhamnosus GG reduces intestinal lipid absorption and the expression of triglyceride synthesis-related genes in mice 98
The short answer: GHK-Cu dosage is individualised - most clinical and research protocols use 0.52 mg per day subcutaneously, but many patients do not inject every day at all
Cerberus supplies it as a research-use-only catalog material for laboratory study
Together, they aim to cover inflammation, blood flow, and tissue rebuilding all at once
An Updated Review of the Literature. Frontiers in Physiology
Psychoneuroendocrinology 32 , 11061115 (2007)